90 Results for "

plasminogen activator inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (90)

90 Results for "plasminogen activator inhibitor" in MCE Product Catalog:

72
72 Publications Verification
Cat. No.: HY-B0285
CAS No.: 2609-46-3
Synonyms: MK-870
Amiloride (MK-870) is an inhibitor of both epithelial sodium channel (ENaC ) and urokinase-type plasminogen activator receptor (uTPA ). Amiloride is a blocker of polycystin-2 (PC2; TRPP2 ) channel.
loading...
    loading...
72
72 Publications Verification
Cat. No.: HY-B0285A
CAS No.: 2016-88-8
Synonyms: MK-870 hydrochloride
Amiloride hydrochloride (MK-870 hydrochloride) is an inhibitor of both epithelial sodium channel (ENaC ) and urokinase-type plasminogen activator receptor (uTPA ). Amiloride hydrochloride is a blocker of polycystin-2 (PC2; TRPP2 ) channel.
loading...
    loading...
72
72 Publications Verification
Cat. No.: HY-B0285B
CAS No.: 17440-83-4
Synonyms: MK-870 hydrochloride dihydrate
Amiloride hydrochloride dihydrate (MK-870 hydrochloride dihydrate) is an inhibitor of both epithelial sodium channel (ENaC ) and urokinase-type plasminogen activator receptor (uTPA ). Amiloride hydrochloride dihydrate is a blocker of polycystin-2 (PC2; TRPP2 ) channel.
loading...
    loading...
50
50 Cited Publications
Cat. No.: HY-B0099
CAS No.: 89-25-8
Synonyms: MCI-186
Edaravone is a strong novel free radical scavenger, and inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-15253
CAS No.: 393105-53-8
Purity:  99.03%
Synonyms: PAI-039; Tiplasinin
Target:  

PAI-1 Apoptosis

Research Areas:  

Metabolic Disease Cancer

Tiplaxtinin is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 μM .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-101761
CAS No.: 1190221-43-2
Purity:  99.08%
Target:  

PAI-1 Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor-1 (PAI-1), has IC50 values between 13.9 and 51.1 μM and induces intrinsic apoptosis in several human cancer cell lines. TM5441 attenuates Nω-nitro-l-arginine methyl ester-induced cardiac hypertension and vascular senescence .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-P2333
CAS No.: 533902-29-3
Target:  

Annexin A

Research Areas:  

Cardiovascular Disease

LCKLSL is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL also inhibits the generation of plasmin and has anti-angiogenic roles .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-P2333A
Target:  

Annexin A

Research Areas:  

Cardiovascular Disease

LCKLSL hydrochloride is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL hydrochloride potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL hydrochloride also inhibits the generation of plasmin and has anti-angiogenic roles .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N1504
CAS No.: 119425-90-0
Loureirin B, a flavonoid extracted from Dracaena cochinchinensis, is an inhibitor of plasminogen activator inhibitor-1 (PAI-1), with an IC50 of 26.10 μM; Loureirin B also inhibits KATP, the phosphorylation of ERK and JNK, and has anti-diabetic activity.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0149
CAS No.: 1197-18-8
Synonyms: cyclocapron
Tranexamic acid (cyclocapron), a cyclic analog of lysine, is an orally active antifibrinolytic agent. Tranexamic acid attenuates the effects of severe trauma, inhibits urokinase plasminogen activator and ameliorates dry wrinkles. Tranexamic acid can used for the research of hemostasis. Tranexamic acid is a PROTAC linker. Tranexamic acid is used to synthesize PROTACs (e.g. LZ-07 (HY-172590)) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111056
CAS No.: 940290-58-4
Purity:  99.72%
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

UK122 is a potent and selective urokinase-type plasminogen activator (uPA) inhibitor with an IC50 of 0.2 μM. UK122 shows no or little inhibition of tissue-type PA (tPA), plasmin, thrombin, and trypsin (all IC50>100 μM). UK122, 4-oxazolidinone analogue, is an anticancer agent and inhibits cancer cell migration and invasion .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111056A
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

UK122 hydrochloride is a potent and selective urokinase-type plasminogen activator (uPA) inhibitor with an IC50 of 0.2 μM. UK122 hydrochloride shows no or little inhibition of tissue-type PA (tPA), plasmin, thrombin, and trypsin (all IC50s > 100 μM). UK122 hydrochloride, a 4-oxazolidinone analogue, is an anticancer agent and inhibits cancer cell migration and invasion .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P70975
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SERPINA5; Acrosomal Serine Protease inhibitor; Prev. PLANH3; PAI-3; Prev. PCI; plasminogen activator inhibitor III; PROCI; plasminogen activator inhibitor-3; PAI3; plasminogen activator inhibitor 3; Protein C inhibitor; Serpin A5; Serine (Or Cysteine) Pro
Species:  
Human
Source:  
HEK293
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16511
CAS No.: 590368-25-5
Synonyms: WX-671
Target:  

PAI-1 Ser/Thr Protease

Research Areas:  

Infection Cancer

Upamostat (WX-671), a prodrug of WX-UK1, is an orally active serine protease inhibitor. Upamostat inhibits the urokinase-type plasminogen activator (uPA) system, blocking the plasminogen activation process mediated by it, thereby suppressing the invasion, migration and metastasis of tumor cells. Upamostat can be used in the research of metastatic breast cancer and locally advanced pancreatic cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-W018723
CAS No.: 2498-50-2
Synonyms: p-Aminobenzamidine dihydrochloride
Target:  

Ser/Thr Protease PAI-1

Research Areas:  

Cardiovascular Disease Cancer

4-Aminobenzamidine (p-Aminobenzamidine) dihydrochloride is a strong trypsin inhibitor. 4-Aminobenzamidine dihydrochloride acts as an orally active urokinase type plasminogen activator (uPA) inhibitor (Ki=82 μM). 4-Aminobenzamidine dihydrochloride can be used for cardiovascular diseases and anti-tumor study .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P71077
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SERPINE1; Endothelial plasminogen activator inhibitor; Prev. PLANH1; Serpin E1; Prev. PAI1; PAI-1; PAI; Serpin Peptidase inhibitor, Clade E (Nexin, plasminogen activator inhibitor Type 1), Member 1; Serine (Or Cysteine) Proteinase inhibitor, Clade E (Nexi
Species:  
Human
Source:  
HEK293
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0111
CAS No.: 67392-87-4
Synonyms: Dihydrospirorenone
Drospirenone (Dihydrospirorenone) is an orally active fourth-generation progestin that interacts with the progesterone receptor (PR) and androgen receptor (AR). Drospirenone significantly decreases both plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) via the AR. Drospirenone can produce DNA damage in bone marrow cells of female mice. .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0518
CAS No.: 483-90-9
Toddalolactone, a main component of Toddalia asiatica, inhibits the activity of recombinant human plasminogen activator inhibitor-1 (PAI-1), with an IC50 value of 37.31 μM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2082
CAS No.: 6743-92-6
Synonyms: Cacticin
Isorhamnetin 3-O-galactoside (Cacticin) is a flavonoid glycoside that can be isolated from Oenanthe javanica, with antithrombotic and profibrinolytic activities. Isorhamnetin 3-O-galactoside inhibits the activities of thrombin and factor Xa (FXa) and reduces thrombin-catalyzed fibrin polymerization maximum rate. Isorhamnetin 3-O-galactoside suppresses TNF-α-induced PAI-1 secretion, decreases the PAI-1/tissue-type plasminogen activator (t-PA) ratio, and inhibits FXa production and FVa/FXa-mediated thrombin generation. Isorhamnetin 3-O-galactoside exerts protective effects against Carbon tetrachloride (CCl4) (HY-Y0298)-induced hepatic injury in mice. Isorhamnetin 3-O-galactoside can be used for the study of liver injury-related diseases and thrombotic vascular diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114330A
CAS No.: 2436760-76-6
Purity:  99.03%
Target:  

PAI-1 Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

ZK824859 hydrochloride is an oral available and selective urokinase plasminogen activator (uPA) inhibitor with IC50s of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively .
loading...
    loading...